Mediscience Award Win
Spectral MD Holdings, Ltd
("Spectral MD" or the "Company" or the Group")
Mediscience Award Win
Spectral MD win Best Technology award at the European Mediscience Awards
LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has won theBest Technologyaward at the European Mediscience Awards, held at Hotel InterContinental, London, last night.
The Best Technology award is awarded for a technology that is innovative, well funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organization or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.
The European Mediscience Awards is the largest annual gathering of private and publicly quoted healthcare, biotech and life sciences companies in Europe, bringing together the best European mediscience companies to celebrate achievement and recognise success.
Wensheng Fan, Chief Executive Officer of Spectral MD, commented: "I was delighted to collect this award last night on behalf of the Spectral MD team. This award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honored to be recognized on an international stage at such a prestigious event."
For further information please contact:
|
Spectral MD Holdings, Ltd. |
investors.spectralmd.com |
|
|
Wensheng Fan, Chief Executive Officer |
via Walbrook PR |
|
|
Nils Windler, Chief Financial Officer |
|
|
|
|
|
|
|
Walbrook PR Ltd (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com |
|
|
Paul McManus / Sam Allen Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258 +44 (0)7407 804 654 |
|
About Spectral MD:
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.
www.spectralmd.com
info@spectralmd.com
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
COMPANIES COVERED:
Latest directors dealings
- 23 hours ago S&U
- 1 day ago Gran Tierra Energy Inc. (CDI)
- 1 day ago Accesso Technology Group
- 1 day ago RHI Magnesita N.V. (DI)
- 1 day ago Reckitt Benckiser Group